This clinical trial tests whether cyrocompression may prevent or reduce peripheral neuropathy in patients receiving chemotherapy. Many patients experience peripheral neuropathy after receiving chemotherapy. This may include numbness, tingling and pain in the hands and feet. Cryotherapy is the treatment of the hands and feet with cold temperatures using ice bags. Compression therapy is the treatment of the hands and feet with surgical compression gloves and compression socks. Cryocompression is a combination of the above two therapies. Giving compression to the hands and feet while receiving chemotherapy may help reduce the amount of peripheral neuropathy that patients experience.
Additional locations may be listed on ClinicalTrials.gov for NCT04563130.
Locations matching your search criteria
United States
North Carolina
Durham
Duke University Medical CenterStatus: Active
Contact: Laura J. Havrilesky
Phone: 919-684-0188
PRIMARY OBJECTIVE:
I. Determine if cryocompression therapy prevents or reduces peripheral neuropathy in patients receiving chemotherapy, both with patient-reported outcomes and an objective clinical measure.
SECONDARY OBJECTIVE:
I. Determine if cryocompression therapy is acceptable and tolerable to patients.
OUTLINE:
Beginning 15 minutes before chemotherapy, patients undergo cyrocompression to either the dominant or non-dominant hand and foot for the duration of chemotherapy until 15 minutes after completion of chemotherapy.
After completion of study treatment, patients are followed up at 30 days.
Trial PhaseNo phase specified
Trial Typeprevention
Lead OrganizationDuke University Medical Center
Principal InvestigatorLaura J. Havrilesky
